Journal article
Telerehabilitation consultations with a physiotherapist for chronic knee pain versus in-person consultations in Australia: the PEAK non-inferiority randomised controlled trial
RS Hinman, PK Campbell, AJ Kimp, T Russell, NE Foster, J Kasza, A Harris, KL Bennell
Lancet | Published : 2024
Abstract
Background: Telerehabilitation whether perceived as less effective than in-person care for musculoskeletal problems. We aimed to determine if physiotherapy video conferencing consultations were non-inferior to in-person consultations for chronic knee pain. Methods: In this non-inferiority randomised controlled trial, we recruited primary care physiotherapists from 27 Australian clinics. Using computer-generated blocks, participants with chronic knee pain consistent with osteoarthritis were randomly assigned (1:1, stratified by physiotherapist and clinic) in-person or telerehabilitation (ie, video conferencing) physiotherapist consultations. Participants and physiotherapists were unmasked to ..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
We acknowledge the contributions of the 15 physiotherapists who provided interventions in this trial (Alexander Wight, Amanda Phillips, Amy Lockyer, Gracia Anggraini, Mathew Smith, Nick Kendrick, Parivesh Kumar, Rob Brandham, Rodney Grof, Simon Callahan, Susan Stokes, Todd Bird, Tom McMillan, Thomas Harris, and Jack Manson) and Ben Metcalf who helped prepare tables. The study was funded by the National Health and Medical Research Council (project grant number 1157977) . RSH is supported by a National Health & Medical Research Council Senior Research Fellowship (grant number 1154217) . KLB is supported by a National Health & Medical Research Council Investigator Grant (grant number 1174431) . NEF is supported by a National Health and Medical Research Council Investigator Grant (grant number 2018182) . The trial protocol was endorsed by the Australia and New Zealand Musculoskeletal Clinical Trial Network, indicating its high priority and quality, importance to consumers or patients, clinicians, and policy makers, and its potential to improve patient outcomes.